Clinical Trial: Nicotinamide Riboside, Vit B3 Analogue, and Brain Energy Metabolism

U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07649161) titled 'Nicotinamide Riboside, Vit B3 Analogue, and Brain Energy Metabolism' on June 08.

Brief Summary: The goal of this clinical trial is to learn how nicotinamide riboside (NR), a form of vitamin B3, affects brain energy metabolism in healthy adults. Researchers want to find out if taking NR by mouth for 2 weeks can raise the balance of two related brain chemicals called NAD+ and NADH, which play a key role in how cells make and use energy. The main questions are: Does short term NR treatment increase the NAD+ to NADH ratio in the brain, and does it change other brain energy measures that we can see with a special type of MRI scan called ...